Literature DB >> 16129851

Patients beware.

Joseph Erban.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16129851      PMCID： PMC1188166          DOI： 10.1503/cmaj.1050064

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.

Authors:  Andreas Laupacis; J Michael Paterson; Muhammad Mamdani; Alaa Rostom; Geoffrey M Anderson
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

2.  Drug approval system questioned in US and Canada.

Authors:  Laura Eggertson
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

3.  Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.

Authors:  Peter Jüni; Linda Nartey; Stephan Reichenbach; Rebekka Sterchi; Paul A Dieppe; Matthias Egger
Journal:  Lancet       Date:  2004 Dec 4-10       Impact factor: 79.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.